After months of consideration, Louisiana officials are proceeding with plans for a so-called Netflix payment model for obtaining hepatitis C treatments at an affordable price.
Specifically, the state is seeking drug makers that would be willing to supply treatments in return for subscription-based payments. In essence, the state would agree to pay a fixed amount of money over five years for unlimited access to medication for anyone who is enrolled in the state Medicaid program or incarcerated in a state prison.
Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!
What is it?
STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.
Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
Subscriber-only networking events and panel discussions across the country
Monthly subscriber-only live chats with our reporters and experts in the field
Discounted tickets to industry events and early-bird access to industry reports
Pharmalot Columnist, Senior Writer
Ed covers the pharmaceutical industry.